Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
about
Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsCurrent and future treatments for hepatocellular carcinomaBridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantationLaparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysisMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaHepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives.Thermal ablation of hepatocellular carcinoma.Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcomeSurvival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma.Review article: liver transplantation for HCC. Treatment options on the waiting list.Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection.Transcatheter arterial chemoembolization of hepatocellular carcinoma as a bridge to liver transplantation: a retrospective study.Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study.Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants.Resection vs thermal ablation of small hepatocellular carcinoma: What's the first choice?Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantationSmaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experienceMultimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapyModel for end-stage liver disease (MELD) for liver allocation: a 5-year score card.Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study.
P2860
Q26783881-773E02E7-F0AB-4354-8835-D6748CBAA3ECQ26801211-0893904F-4838-43DD-B5A8-07FF5C7D8692Q26852105-D5CCBA5B-64BC-4F86-8662-6371E7462460Q26864259-474F27E4-7485-443D-81E7-094EF32DE00FQ26998606-2151571F-0F3E-4019-ACA2-07A8B78759A6Q27005375-9B67478F-7327-4790-B88A-96609B6657A7Q28392783-433E0BE0-6FE1-4CC1-8014-A50229BD355EQ28394414-E98B5297-3824-4C5E-8071-A75BEE0F2802Q30430659-07D85A43-CA3D-4AE3-8333-0F3E7192B0A3Q33237223-0DAB1524-BC9E-4302-90DB-DBE5F3D2D7C8Q33323261-9A7860C0-80A0-4D5D-8B34-EA74EBA41C45Q33514014-60BCC23D-856F-48FF-A1EB-BFEFA3AEAEBEQ33872038-70BD4506-2098-43BF-9383-7FBFD59C0735Q33960740-8AF4456F-7BD1-41A7-A354-90E25D6CC887Q34067940-0954893A-A7EE-4BB2-8738-45155A27016FQ34080984-295EFDA8-A749-47BE-918F-B28AA12A3D4FQ34131801-24343B71-DB16-4ADF-A62B-4C98148471D3Q34207805-37A80C41-4380-4C39-A71B-257B65812685Q34618740-06662447-D80D-4B8F-BE3B-3D1FE5B0B9C8Q35081063-D6AED30D-DEB0-406E-A03F-45B830145825Q35133600-6C0F50A8-BA12-45B3-B79B-A68D19879361Q35145063-D51394F7-5D86-4491-A967-90DEE40C41FAQ35145087-4ED8D55B-29B6-49D0-AA00-958B0F7B3D1BQ35207490-A85A7CED-EBDF-4735-8543-9E3535DCFD9EQ35207822-16F4A91C-1BC4-4F90-ACFC-9C503BACE78BQ35422169-362F870A-BA96-4942-AE9A-F97552FAD92AQ35613914-161D568C-4772-47A5-8F58-4813085D54B1Q35625989-C033F822-CFE3-4174-B8B7-605D3AD9D4D7Q35751531-1ED56122-D35E-4B97-BD31-9244481DD73DQ36681469-3C69C9F0-9EA3-4F25-B9FB-F35B3D0E7B9BQ36720150-3C0813DE-585E-4BEE-9F14-B595D5D8D3A8Q36924891-710F9A82-32AC-431B-A2DD-1E3714979E41Q36937325-2A656098-76B1-4756-BA6E-43AB4FC2EA86Q36950674-3AB0BF9A-05EA-4EAA-AC61-2A686A67C43EQ37034067-91ED6B1B-C8D3-42D6-9587-78C19349DCE2Q37045547-60045504-279A-4341-ACC6-1D0FC0181A88Q37068256-70F6785D-CC49-48E9-9A9D-400211C9AA17Q37212974-BA98BA2B-305C-4CE9-9EB2-846BBA4E86CFQ37247967-F2F9B84C-A29C-452B-AB39-D4EBBAA670B0Q37348269-20B0DECE-CA47-422A-A064-F86459ACB72C
P2860
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Liver transplantation for hepa ...... dropout from the waiting list.
@en
type
label
Liver transplantation for hepa ...... dropout from the waiting list.
@en
prefLabel
Liver transplantation for hepa ...... dropout from the waiting list.
@en
P2093
P2860
P356
P1476
Liver transplantation for hepa ...... dropout from the waiting list.
@en
P2093
Bev Nikolai
Francis Y Yao
John P Roberts
Nancy L Ascher
Nathan M Bass
Robert Kerlan
Timothy J Davern
P2860
P304
P356
10.1053/JLTS.2002.34923
P577
2002-10-01T00:00:00Z